Adrian Wildfire Adrian Wildfire is Project Director of the SGS Clinical Research Human Challenge Unit.

Adrian Wildfire has worked as an infectious disease specialist for over 30 years, having trained and worked within the fields of bacteriology, virology, parasitology and mycology after obtaining his Fellowship in Medical Microbiology in 1990, and a Masters in Parasitology in 1998. He has specialised in Human Challenge Models for nearly 10 years and is currently leading a multidisciplinary team manufacturing challenge agents for use in clinical trials. He is the author of numerous published papers and articles relating to HIV, ethics and viral challenge amongst others.

Content by Adrian Wildfire:

Manufacture Vaccines

The Pandemic Diaries

05/19/2020 | Mike Grippo, Andy Lane, Adrian Wildfire

We asked medicine makers around the world to tell us how their professional and personal lives have changed during the ongoing COVID-19 crisis.

Discovery & Development Clinical Trials

Failing Safely: Why Ending Some Programmes Early May Be a Recipe for Successes Later

02/27/2020 | Adrian Wildfire

Why are compounds still failing at the final hurdle?

Manufacture Clinical Trials

The Winning Formula

06/13/2018 | Adrian Wildfire

We must find ways to better help vaccine manufacturers to fight the flu – and this is why we developed a new challenge agent for H3N2.

Manufacture Clinical Trials

The Human Challenge

02/22/2017 | Adrian Wildfire

Human challenge studies could allow us to better predict vaccines' real-world efficacy.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Medicine Maker magazine